Business Context and Reporting Period
This Form 8-K is a current report filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd) on April 15, 2025. The registrant is a Delaware corporation with its principal executive offices in Omaha, NE. The company is classified as an emerging growth company and its common stock (KLTO) and warrants (KLTOW) are listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status regarding stock listing requirements.
Material Changes and Listing Status
- Delisting Notices: The company received multiple notices from Nasdaq regarding non-compliance with listing rules, including the Minimum Market Value of Publicly Held Shares (MVPHS), Minimum Market Value of Listed Securities (MVLS), and the Bid Price Rule (stock closing below $1.00 for 30 consecutive days).
- Extension Granted: Following a hearing on March 27, 2025, the Nasdaq Hearings Panel granted an extension until August 13, 2025, to regain compliance with the Bid Price Rule, contingent on achieving specific milestones.
- New Deficiency: On April 15, 2025, Nasdaq issued a notice stating the company has not regained compliance with the applicable rule. The Panel will consider this new deficiency in its final decision regarding continued listing.
- Response Deadline: The company must present its views regarding this additional deficiency to the Panel in writing by April 22, 2025.
Outlook, Management Commentary, and Risks
Management believes its previously presented Compliance Plan demonstrates the ability to achieve full compliance with Nasdaq Listing Rules by August 3, 2025. The primary risk is the potential revocation or termination of the extension period if the company fails to satisfy the required milestones, which could lead to delisting. The company intends to timely submit its written response to the new deficiency notice.
Investor Verification Checklist
- Verify the current bid price of KLTO stock to assess compliance with the $1.00 minimum requirement.
- Monitor the company's progress against the specific milestones required for the extension granted until August 13, 2025.
- Review the written response the company submits to the Nasdaq Panel by April 22, 2025.
- Check for any subsequent announcements regarding the final decision of the Nasdaq Hearings Panel on the company's continued listing.